Myceen / PAKK Pavilion – Mycelium-Coir Composite Insulation in Live Envelope Trial

Product · Building Envelope

Product · InnDex 35 · Evidence provided · High specification risk

Mycelium-based composite insulation panels in 24-month live building envelope trial.

Myceen grows mycelium into agricultural residues and sawdust to create lightweight insulation boards. The PAKK Pavilion trial addresses the need for non-petrochemical, biodegradable envelope insulation with lower embodied carbon than mineral wool. Panels are deployed within a timber structure under real-world conditions with thermal and mould monitoring through October 2026.

Myceen grows insulation boards from mycelium and agricultural waste — sawdust, coir — and the PAKK Pavilion is running a 24-month live envelope trial to test thermal performance and mould resistance under real northern European conditions, with monitoring running through October 2026. The material proposition is compelling from a circular-economy angle: fully biodegradable end-of-life, locally cultivated feedstock, and a potentially lower embodied-carbon footprint than mineral wool if claims are validated. The critical qualifier is that no independent lambda certification or accredited thermal data has been published; the trial is still in progress and no interim results have been disclosed, so the performance case rests entirely on claimed values. The two most significant barriers to specification are the critical-severity regulatory gap — no declared performance under EN 13823 or equivalent fire and durability standards — and the fundamental mismatch between a claimed 6-to-24-month durability window and the 30-to-50-year design life expected of a building envelope. Hygroscopic behaviour and moisture management detailing requirements also need independent characterisation before this can be used in anything other than a controlled demonstration. Worth monitoring as the trial data emerges; not yet suitable for specification on a live project unless the project is itself structured as a research demonstration.

Strengths

• Biodegradable and compostable end-of-life vs. persistent mineral fibres
• Claimed superior thermal resistance density and lower embodied carbon footprint
• Locally cultivated feedstock (sawdust, agricultural waste) reduces supply chain impact
• Early data suggests mould resistance despite hygroscopic substrate
• Lightweight panel handling improves on-site safety and labour

Considerations

• No independent lambda certification or third-party thermal data; claims unvalidated by accredited labs (high)
• Hygroscopic material requires careful detailing and vapor management; performance sensitive to humidity control (moderate)
• Biological material may require specific storage, handling, and installation protocols to avoid colonization pre-deployment (moderate)
• Long-term durability and structural integrity (creep, density loss) unproven beyond 24 months (high)

Risks

• Live trial monitoring data not yet public; no interim results disclosed; final outcomes still 12+ months away (high)
• Mould risk remains theoretical — single pavilion in controlled timber design may not represent performance in high-moisture climates, retrofit, or poor detailing scenarios (moderate)
• Regulatory pathway unclear: no declared performance under EN 13823 or equivalent; fire classification, humidity class limits, and durability standards not established (critical)
• Scale-up manufacturing, cost competitiveness, and consistency undemonstrated; pilot to market viability unproven (moderate)
• Mycelium colonization of adjacent structures or pest attraction not addressed in public materials (low)

Performance

• Trial duration: Oct 2024 – Oct 2026
• Claimed thermal resistance: Better than mineral wool (self-reported, no lambda published)
• Mould/condensation observed: None (preliminary)
• Grant funding secured: €2M (Estonian public + EU co-funding)

Reality check

Single live deployment exists (PAKK Pavilion, Oct 2024 onward), but monitoring period is incomplete (24-month trial not yet finished). Myceen's preliminary thermal and mould claims lack independent laboratory verification, lambda values, or published third-party test reports. Company is pre-commercial, €2M in public grants secured, seeking seed for pilot factory—typical early-stage funding pattern. No fire classification, moisture durability, or long-term embodied-carbon data published. Source is investment portal, not peer-reviewed or independent technical literature.

#mycelium #bio-based_insulation #envelope #live_trial #embodied_carbon #thermal

Source